Valuation : Brooks Laboratories Limited

Market Cap 186.46Cr 1.97Cr 1.69Cr 1.59Cr 1.45Cr 2.71Cr 2.72Cr 19Cr 7.29Cr 95Cr 7.39Cr 7.22Cr 303.29Cr P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 188.31Cr 1.99Cr 1.71Cr 1.61Cr 1.47Cr 2.74Cr 2.75Cr 19Cr 7.37Cr 96Cr 7.46Cr 7.3Cr 306.29Cr EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
44.12%
Yield 2025 *
-
Yield 2026 -
13/08 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
17/07 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
19/06 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
29/05 Brooks Laboratories appoints Prashant Rathi as CEO RE
29/05 Brooks Laboratories names Prashant Rathi as CEO RE
29/05 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
29/05 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
06/02 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
16/25/16 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
13/25/13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
28/25/28 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
13/25/13 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
26/24/26 Brooks Laboratories Limited Appoints Ms. Krutika Mohan Rane as Company Secretary & Compliance Officer, Effective 26 December 2024 CI
1 day-0.49%
1 week-3.24%
Current month-5.34%
1 month+5.16%
3 months-7.68%
6 months+7.75%
Current year-21.40%
1 week 61.15
Extreme 61.15
70.8
1 month 58.5
Extreme 58.5
71.4
Current year 36.3
Extreme 36.3
82.44
1 year 36.3
Extreme 36.3
163.9
3 years 36.3
Extreme 36.3
198.86
5 years 36.3
Extreme 36.3
198.86
10 years 13.85
Extreme 13.85
198.86
Manager TitleAgeSince
Chief Executive Officer 58 23/01/2002
Chief Executive Officer - 01/06/2026
President 57 23/08/2023
Director TitleAgeSince
Director/Board Member 53 23/11/2022
Director/Board Member 62 10/09/2010
Director/Board Member - 23/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%-3.24%-56.80%-43.81% 1.97Cr
-1.11%-3.46%+17.16%+64.03% 4.77TCr
-1.06%-4.22%+37.16%+118.27% 4.02TCr
-1.58%-2.32%+8.86%+79.37% 1.21TCr
-1.51%-3.52%-12.15%+9.28% 1.18TCr
-0.76%-1.70%+20.93%+136.36% 915.56Cr
-0.64%-2.34%+20.19%+32.91% 734.33Cr
-2.95%-4.74%+34.84%-17.47% 738.84Cr
-1.60%-1.02%+15.06%+200.27% 736.58Cr
-0.77%-2.48%-46.84%+21.17% 513.21Cr
Average -1.25%-2.41%+3.84%+60.04% 1.48TCr
Weighted average by Cap. -1.23%-2.75%+18.51%+79.77%

Financials

2025 2026
Net sales 83Cr 87.08L 74.87L 70.44L 64.28L 1.2Cr 1.21Cr 8.35Cr 3.23Cr 42Cr 3.27Cr 3.2Cr 134.28Cr 86Cr 90.44L 77.76L 73.15L 66.76L 1.25Cr 1.25Cr 8.67Cr 3.35Cr 44Cr 3.4Cr 3.32Cr 139.46Cr
Net income -9.97Cr -10.51L -9L -9L -8L -14.48L -14.56L -1.01Cr -38.98L -5.09Cr -39.48L -38.62L -16Cr 25Cr 25.93L 22.3L 20.98L 19.14L 35.72L 35.91L 2.49Cr 96.15L 13Cr 97.37L 95.25L 40Cr
Net Debt 7.54Cr 8L 7L 6L 6L 10.96L 11.01L 76.22L 29.49L 3.85Cr 29.86L 29.21L 12Cr 1.84Cr 2L 2L 2L 1L 3L 3L 18.64L 7L 94.24L 7L 7L 3Cr
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
09/26/09 62.99 -0.49% 17,284
08/26/08 ₹63.30 -6.50% 64,342
07/26/07 ₹67.70 +2.47% 25,779
04/26/04 ₹66.07 +2.99% 12,920
03/26/03 ₹64.15 -1.46% 24,891
  1. Stock Market
  2. Stocks
  3. BROOKS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!